Advancements in medical imaging have allowed technicians and researchers to identify preclinical Alzheimer’s, which was previously extremely difficult. Imaging techniques search for deposits of the protein amyloid-beta, which interferes with the brain’s communication system and is an indicator of Alzheimer’s disease. Genetic tests can also determine if a person is likely to develop the condition if it runs in their family.

This site offers information designed for educational purposes only. You should not rely on any information on this site as a substitute for professional medical advice, diagnosis, treatment, or as a substitute for, professional counseling care, advice, diagnosis, or treatment. If you have any concerns or questions about your health, you should always consult with a physician or other healthcare professional.